The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Exhausted activation of microglia is crucial to promoting T cell infiltration into the brain, which exacerbates neuroinflammation and neurodegeneration and impairs cognition, in two different mouse models of tauopathy (THY-tau22 and PS19 mice).
“Recent reports in two different mouse models of tauopathy (THY-tau22 and PS19 mice) suggest that exhausted activation of microglia is crucial to promoting the T cell infiltration into the brain, which exacerbates neuroinflammation and neurodegeneration and impairs cognition (Laurent et al., 2017; Chen et al., 2023).”
From Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy (2024) · cites this paper as Laurent et al., 2017
The Discussion (page unavailable) reports microglial CCL3 production before T-cell infiltration in THY-Tau22 mice, but says it *could* contribute to recruitment; it does not establish that exhausted microglial activation is crucial. The Results, “T cell depletion restrains cognitive deficits in THY-Tau22 mice” (page unavailable), support a role for infiltrating T cells in neuroinflammation and cognitive decline. This paper studies THY-Tau22, not PS19, and its Discussion describes T-cell recruitment in the absence of neuronal death rather than showing that infiltration exacerbates neurodegeneration. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 2×
“Of note, it was recently suggested that the complement-dependent pathway of synaptic pruning by microglia is inappropriately activated and mediate synapse loss in Alzheimer’s disease (Hong et al., 2016).”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639 · cited 3×
“In a detrimental circle, microglia activation was suggested to play an important role in the development/spreading of tau pathology and associated memory deficits (Yoshiyama et al., 2007; Gorlovoy et al., 2009; Bhaskar et al., 2010; Nash et al., 2013; Asai et al., 2015).”
BackgroundJones, L., Holmans, P. A., Hamshere, M. L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013950 · Cited by 606
Baruch, K., Rosenzweig, N., Kertser, A., Deczkowska, A., Sharif, A. M., Spinrad, A., Tsitsou-Kampeli, A., Sarel, A., Cahalon, L., & Schwartz, M. (2015) · Nature Communications · doi:10.1038/ncomms8967 · Cited by 491
TLR2 Is a Primary Receptor for Alzheimer’s Amyloid β Peptide To Trigger Neuroinflammatory Activation
Liu, S., Liu, Y., Hao, W., Wolf, L., Kiliaan, A. J., Penke, B., Rübe, C. E., Walter, J., Heneka, M. T., Hartmann, T., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101121 · Cited by 439
Baruch, K., Deczkowska, A., Rosenzweig, N., Tsitsou-Kampeli, A., Sharif, A. M., Matcovitch-Natan, O., Kertser, A., David, E., Amit, I., & Schwartz, M. (2016) · Nature Medicine · doi:10.1038/nm.4022 · Cited by 425
Zommer, N., Sergeant, N., Schraen-Maschke, S., Blum, D., & Buee, L. (2012) · Current Alzheimer Research · doi:10.2174/156720512800492503 · Cited by 193
Self-citationAccumulation of tau induced in neurites by microglial proinflammatory mediators
Gorlovoy, P., Larionov, S., Pham, T. T. H., & Neumann, H. (2009) · The FASEB Journal · doi:10.1096/fj.08-123877 · Cited by 156
Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
Nash, K. R., Lee, D. C., Hunt, J. B., Morganti, J. M., Selenica, M.-L., Moran, P., Reid, P., Brownlow, M., Guang-Yu Yang, C., Savalia, M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.011 · Cited by 108
Flagged first, then by citations
Research works printed but not linked: 55
- Ahmed, 2015, Rescue of impaired late-phase long-term depression in a tau transgenic mouse model, Neurobiol Aging, 36, 730, 10.1016/j.neurobiolaging.2014.09.015 · DOI
- 10.1038/nn.4132 · DOI · Paper page
- 10.1016/j.nbd.2011.04.022 · DOI
- 10.1016/S0002-9440(10)63421-9 · DOI
- 10.1159/000322228 · DOI
- 10.1186/s40478-015-0186-2 · DOI · Paper page
- 10.1097/NEN.0b013e318232a379 · DOI · Paper page
- 10.4049/jimmunol.1200947 · DOI
- 10.1093/hmg/ddv268 · DOI · Paper page
- 10.2174/156720512800492468 · DOI
- 10.1111/acel.12018 · DOI
- 10.1016/S0165-0270(96)00121-5 · DOI
- 10.1016/j.nbd.2008.12.015 · DOI
- 10.1093/brain/awv408 · DOI
- 10.1212/WNL.52.6.1158 · DOI · Paper page
- 10.1016/S0197-4580(97)80306-5 · DOI · Paper page
- 10.1016/j.nbd.2006.03.008 · DOI
- 10.4049/jimmunol.178.8.4865 · DOI
- 10.1084/jem.20070064 · DOI
- 10.3389/fpsyt.2010.00136 · DOI · Paper page
- 10.1016/S0197-4580(99)00063-9 · DOI
- 10.1007/s00441-012-1427-3 · DOI
- Jones, 2015, How dependent is synaptic plasticity on microglial phenotype?, Neuropharmacology, 96, 3, 10.1016/j.neuropharm.2014.08.012 · DOI
- 10.1007/s12026-012-8327-1 · DOI
- Lambert, 2010, Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis, J Alzheimers Dis, 20, 1107, 10.3233/JAD-2010-100018 · DOI · Paper page
- 10.1016/j.neurobiolaging.2014.03.027 · DOI
- Laurent, 2016, A2A adenosine receptor deletion is protective in a mouse model of Tauopathy, Mol Psychiatry, 21, 97, 10.1038/mp.2014.151 · DOI
- 10.2337/db12-0866 · DOI
- 10.1016/j.tins.2013.01.008 · DOI
- 10.1016/j.neurobiolaging.2014.08.008 · DOI
- 10.1016/j.neurobiolaging.2006.02.013 · DOI
- Marciniak, 2015, The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory, Sci Rep, 5, 15862, 10.1038/srep15862 · DOI · Paper page
- 10.1073/pnas.82.12.4245 · DOI · Paper page
- Minatohara, 2016, Role of immediate-early genes in synaptic plasticity and neuronal ensembles underlying the memory trace, Front Mol Neurosci, 8, 78, 10.3389/fnmol.2015.00078 · DOI
- 10.1172/JCI200318104 · DOI · Paper page
- 10.1073/pnas.0506209103 · DOI
- Papegaey, 2016, Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation, Acta Neuropathol Comm, 4, 74, 10.1186/s40478-016-0345-0 · DOI
- 10.1016/j.neuropharm.2014.12.020 · DOI
- 10.1016/j.mcn.2011.09.004 · DOI
- 10.1523/JNEUROSCI.4393-13.2014 · DOI
- 10.1016/S0197-4580(88)80079-4 · DOI · Paper page
- Rosset, 2015, Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer's disease, J Neuroinflamm, 12, 95, 10.1186/s12974-015-0317-5 · DOI
- 10.1016/j.brainres.2008.02.084 · DOI
- Sauer, 2013, Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism, Neurobiol Dis, 59, 194, 10.1016/j.nbd.2013.07.010 · DOI
- 10.2353/ajpath.2006.060002 · DOI
- 10.1586/14789450.5.2.207 · DOI · Paper page
- 10.1016/j.immuni.2013.02.012 · DOI · Paper page
- 10.1523/JNEUROSCI.2545-05.2005 · DOI
- 10.1016/S0165-5728(01)00496-9 · DOI · Paper page
- 10.1128/JVI.77.7.4004-4014.2003 · DOI
- 10.1016/j.nlm.2010.12.005 · DOI
- Van der Jeugd, 2013, Progressive age-related cognitive decline in tau mice, J Alzheimers Dis, 37, 777, 10.3233/JAD-130110 · DOI
- Vidal, 1990, Tissue-specific control elements of the Thy-1 gene, EMBO J, 9, 833, 10.1002/j.1460-2075.1990.tb08180.x · DOI
- 10.1172/JCI41911 · DOI
- 10.1093/brain/awt210 · DOI · Paper page
Cited by
Sorted by citations
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
NLRP3 inflammasome activation drives tau pathology
Ising, C., Venegas, C., Zhang, S., Scheiblich, H., Schmidt, S. V., Vieira-Saecker, A., Schwartz, S., Albasset, S., McManus, R. M., Tejera, D., et al. (2019) · Nature · doi:10.1038/s41586-019-1769-z · Cited by 1,487
Self-citationInflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
Bettcher, B. M., Tansey, M. G., Dorothée, G., & Heneka, M. T. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00549-x · Cited by 427
Self-citationTau and neuroinflammation: what impact for Alzheimer's disease and tauopathies?
Laurent, C., Buée, L., & Blum, D. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.01.003 · Cited by 348
Self-citationEmerging roles of innate and adaptive immunity in Alzheimer’s disease
Chen, X., & Holtzman, D. M. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.016 · Cited by 297
Minter, M. R., Hinterleitner, R., Meisel, M., Zhang, C., Leone, V., Zhang, X., Oyler-Castrillo, P., Zhang, X., Musch, M. W., Shen, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11047-w · Cited by 292
Unger, M. S., Li, E., Scharnagl, L., Poupardin, R., Altendorfer, B., Mrowetz, H., Hutter-Paier, B., Weiger, T. M., Heneka, M. T., Attems, J., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.070 · Cited by 248
Propson, N. E., Roy, E. R., Litvinchuk, A., Köhl, J., & Zheng, H. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140966 · Cited by 258
Hosseini, S., Wilk, E., Michaelsen-Preusse, K., Gerhauser, I., Baumgärtner, W., Geffers, R., Schughart, K., & Korte, M. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1740-17.2018 · Cited by 236
Jorfi, M., Park, J., Hall, C. K., Lin, C.-C. J., Chen, M., von Maydell, D., Kruskop, J. M., Kang, B., Choi, Y., Prokopenko, D., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01415-3 · Cited by 214
Intersection of pathological tau and microglia at the synapse
Vogels, T., Murgoci, A.-N., & Hromádka, T. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0754-y · Cited by 197
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Dionisio-Santos, D. A., Olschowka, J. A., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1453-0 · Cited by 184
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
Mayne, K., White, J. A., McMurran, C. E., Rivera, F. J., & de la Fuente, A. G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.572090 · Cited by 167
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Zang, X., Chen, S., Zhu, J., Ma, J., & Zhai, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.872134 · Cited by 139
Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
Zhang, X., Pearsall, V. M., Carver, C. M., Atkinson, E. J., Clarkson, B. D. S., Grund, E. M., Baez-Faria, M., Pavelko, K. D., Kachergus, J. M., White, T. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33226-8 · Cited by 102
Role of Chemokines in the Development and Progression of Alzheimer’s Disease
Wojcieszak, J., Kuczyńska, K., & Zawilska, J. B. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02047-1 · Cited by 97
“Overexpression of CCL3, CCL4, and CCL5, paralleled by infiltration of T lymphocytes into the hippocampus, was also observed in a Tg murine model of tauopathy, THY-Tau22 (Laurent et al.”
BackgroundKim, D. K., Park, J., Han, D., Yang, J., Kim, A., Woo, J., Kim, Y., & Mook-Jung, I. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0234-4 · Cited by 95
Kiyota, T., Machhi, J., Lu, Y., Dyavarshetty, B., Nemati, M., Yokoyama, I., Mosley, R. L., & Gendelman, H. E. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.009 · Cited by 80
Microbiota‐microglia connections in age‐related cognition decline
Zhou, R., Qian, S., Cho, W. C. S., Zhou, J., Jin, C., Zhong, Y., Wang, J., Zhang, X., Xu, Z., Tian, M., et al. (2022) · Aging Cell · doi:10.1111/acel.13599 · Cited by 71
Toral-Rios, D., Long, J. M., Ulrich, J. D., Yu, J., Strickland, M. R., Han, X., Holtzman, D. M., Cashikar, A. G., & Paul, S. M. (2024) · Journal of Experimental Medicine · doi:10.1084/jem.20232000 · Cited by 47
Statins: Neurobiological underpinnings and mechanisms in mood disorders
Walker, A. J., Kim, Y., Borissiouk, I., Rehder, R., Dodd, S., Morris, G., Nierenberg, A. A., Maes, M., Fernandes, B. S., Dean, O. M., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.012 · Cited by 33
Zhu, T., Zhang, F., Li, H., He, Y., Zhang, G., Huang, N., Guo, M., & Li, X. (2019) · Clinical Interventions in Aging · doi:10.2147/cia.s208068 · Cited by 33
Zhang, H., Wang, D., Gong, P., Lin, A., Zhang, Y., Ye, R. D., & Yu, Y. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180823 · Cited by 26
Vautheny, A., Duwat, C., Aurégan, G., Joséphine, C., Hérard, A.-S., Jan, C., Mitja, J., Gipchtein, P., Gaillard, M.-C., Buée, L., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105398 · Cited by 28
Self-citationDifferences in peripheral immune system gene expression in frontotemporal degeneration
Sawyer, R. P., Hill, E. J., Yokoyama, J., Medvedovic, M., Ren, Y., Zhang, X., Choubey, D., Shatz, R. S., Miller, B., & Woo, D. (2022) · Medicine · doi:10.1097/md.0000000000028645 · Cited by 9
Metadata
- Authors
- Laurent, C., Dorothée, G., Hunot, S., Martin, E., Monnet, Y., Duchamp, M., Dong, Y., Légeron, F.-P., Leboucher, A., Burnouf, S., Faivre, E., Carvalho, K., Caillierez, R., Zommer, N., Demeyer, D., Jouy, N., Sazdovitch, V., Schraen-Maschke, S., Delarasse, C., Buée, L., & Blum, D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-05
- Volume
- 140
- Issue
- 1
- Pages
- 184-200
- ISSN
- 0006-8950
- 1460-2156
- PMC
- PMC5382942
- Cited by
- 303
- References
- 15
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review